Recent News About DLA Piper
-
DLA Piper advised SolarWinds Corporation (SolarWinds), a leading provider of simple, powerful, secure observability and IT management software, in entering into a definitive agreement to be acquired by funds managed by Turn/River in an all-cash transaction for $18.50 per share or approximately $4.4 billion.
-
DLA Piper is pleased to announce that Bruce Falby, a partner in the firm’s Boston office, was named to Massachusetts Lawyers Weekly's 2024 Go-To Business Litigation Lawyers list honoring the top business litigators in Massachusetts.
-
DLA Piper International today announces its new Executive Committee, appointed by International Managing Partner and Global Co-CEO Elect, Charles Severs.
-
DLA Piper is pleased to announce that Gerry Williams has been named Co-US Managing Partner of the firm.
-
DLA Piper advised Alimera Sciences, Inc., a global pharmaceutical company focused on ophthalmic solutions, in its acquisition by ANI Pharmaceuticals, a diversified biopharmaceutical company, in a transaction that values Alimera at approximately US$381 million in up front consideration plus contingent value rights providing for additional consideration upon the achievement of certain revenue milestones.
-
DLA Piper’s international patent team has once again been recognised by IAM Patent 1000: The World's Leading Patent Professionals, which has named 37 DLA Piper lawyers from eleven countries in its global guide of top patent professionals.
-
DLA Piper is pleased to welcome Steve Dixon as a partner in the Tax Practice.
-
DLA Piper announced that Daniel Garen has joined the firm’s Litigation and Regulatory practice as a partner in Washington, DC.
